The Discounted Cash Flow (DCF) valuation of FibroGen Inc (FGEN) is (42.86) USD. With the latest stock price at 9.71 USD, the upside of FibroGen Inc based on DCF is -541.4%.
Based on the latest price of 9.71 USD and our DCF valuation, FibroGen Inc (FGEN) is a sell. selling FGEN stocks now will result in a potential gain of 541.4%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 20.2% | 12.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,039.63) - (11.71) | (42.86) |
| Upside | -10806.8% - -220.6% | -541.4% |